Clearside Biomedical Adds Board Member
This article was originally published in Scrip
Clearside Biomedical Inc., a company focused on therapies for blinding diseases of the eye, has appointed Richard J. Croarkin to its board of directors. Previously, Croarkin was chief financial officer (CFO) of Nestlé Health Science S.A. and served as senior vice president of finance, chief financial officer and corporate strategy officer at Alcon, Inc. Prior to Alcon, he was executive vice president and CFO of Nestlé Waters North America and before this, he held various global senior financial positions at Pepsico Inc.
Register for our free email digests: